Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference Johnson & Johnson (NYSE: JNJ) will participate in the 2014 Citi Global Health Care Conference on Monday, Feb. 24, at the Hilton New York Hotel in New ...

Key Takeaway: NEW BRUNSWICK, N.J. , Feb. 14, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2014 Citi Global Health Care Conference on Monday, Feb. 24 , at the Hilton New York Hotel in New York , NY. Joaquin Duato , Worldwide Chairman, Pharmaceuticals, will represe

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Feb. 14, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2014 Citi Global Health Care Conference on Monday, Feb. 24 , at the Hilton New York Hotel in New York , NY. Joaquin Duato , Worldwide Chairman, Pharmaceuticals, will represent the Company as the keynote speaker, and is scheduled to present at 8:00 a.m. (Eastern).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
Last updated: Feb 14, 2014